THROMBOCYTHEMIA, ESSENTIAL
Clinical trials for THROMBOCYTHEMIA, ESSENTIAL explained in plain language.
Never miss a new study
Get alerted when new THROMBOCYTHEMIA, ESSENTIAL trials appear
Sign up with your email to follow new studies for THROMBOCYTHEMIA, ESSENTIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood cancer drug bomedemstat gets Long-Term safety check in 400 patients
Disease control Recruiting nowThis study is for people with certain blood cancers (like essential thrombocythemia or myelofibrosis) who are already doing well on the drug bomedemstat. It aims to collect long-term safety information and see how well the drug continues to work. About 400 participants will conti…
Matched conditions: THROMBOCYTHEMIA, ESSENTIAL
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
New registry aims to unlock secrets of rare blood cancers
Knowledge-focused Recruiting nowThis study is a long-term registry for people with myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Researchers will collect health records, surveys, and insurance data from 5,000 participants over at least five years to understand how the disease progresses an…
Matched conditions: THROMBOCYTHEMIA, ESSENTIAL
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated May 26, 2026 07:23 UTC